A Pharmacokinetic Study of a Single-Dose of DZNS in Adult Epileptic Patients Experiencing a Seizure Episode
| Status: | Completed |
|---|---|
| Conditions: | Neurology, Epilepsy |
| Therapuetic Areas: | Neurology, Other |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 11/11/2012 |
| Start Date: | September 2011 |
| End Date: | January 2012 |
| Contact: | Kelly Abernathy |
| Email: | kabernathy@neuronexinc.com |
An Open-Label Study to Determine the Pharmacokinetics of a Single Dose of DZNS in Adult Epileptic Patients Experiencing a Seizure Episode for Which Acute Treatment With a Benzodiazepine is Clinically Indicated
The purpose of this study is to determine the pharmacokinetics of DZNS following a single
dose in epileptic patients experiencing a seizure episode.
Inclusion Criteria:
- Provide signed informed consent for study participation.
- General good health with no clinically significant unstable abnormalities.
- Diagnosis of epilepsy.
Exclusion Criteria:
- Individuals receiving warfarin (Coumadin®) or dabigatran (Pradaxa®).
- Use of any investigational drug within 30 days.
- Blood or plasma donation within 30 days.
- Not willing or unable to tolerate blood draws.
We found this trial at
3
sites
Johns Hopkins University The Johns Hopkins University opened in 1876, with the inauguration of its...
Click here to add this to my saved trials
Vanderbilt University Vanderbilt offers undergraduate programs in the liberal arts and sciences, engineering, music, education...
Click here to add this to my saved trials
Thomas Jefferson University We are dedicated to the health sciences and committed to educating professionals,...
Click here to add this to my saved trials